Delaware is the latest state to accuse pharmaceutical manufactures of jacking up insulin prices, even as the cost to produce diabetes medications has decreased.
(CN) — Delaware accuses manufacturers and pharmaceutical companies of working together to drive up drug prices for Delaware diabetics and to foreclose access to lower priced diabetic treatments in order to increase their profits.
Additional Reads
Read Full Article: https://www.courthousenews.com/delaware-sues-pharma-companies-over-raising-insulin-prices/
